MEGALASE — Alpha-Amylase

Anti-inflammatory and Anti-edematous Enzyme Preparation | Tablets and Syrup

Therapeutic Category: Enzyme Preparation | Anti-inflammatory Adjunct

Active Ingredient: Alpha-amylase

Megalase contains alpha-amylase, an enzyme preparation traditionally used as an adjunct in the management of certain inflammatory and edematous conditions. Alpha-amylase is best known for its role in breaking down starch; pharmaceutical formulations containing the enzyme have also been marketed for symptomatic relief of mild inflammatory conditions, particularly congestion and discomfort involving the oropharynx.

Megalase is available as film-coated tablets and oral syrup, providing alternative dosage forms for patients when appropriate. The syrup may be more suitable for patients who have difficulty swallowing tablets, subject to the product's age-specific instructions.

Clinical evidence note: Alpha-amylase is marketed in some countries for anti-inflammatory purposes, but the strength of evidence for reducing swelling and inflammation is limited. It should not be considered a replacement for treatment of the underlying cause of inflammation.

Indications and Potential Benefits

Megalase may be used as an adjunct, according to the locally approved product information, for:

• Anti-inflammatory support: Traditionally used to help relieve symptoms associated with selected inflammatory conditions.
• Anti-edematous action: Intended to help reduce localized swelling associated with certain inflammatory conditions.
• Oropharyngeal congestion: May be used for mild throat discomfort and congestion without fever, where approved.
• Post-procedural swelling: May be considered as an adjunct following selected dental or ENT procedures when recommended by a healthcare professional.
• Digestive enzyme activity: Alpha-amylase breaks down starch into smaller carbohydrate molecules. However, Megalase should not automatically be considered a treatment for indigestion or pancreatic enzyme deficiency.

The appropriate indication depends on the product's approved labeling and the patient's clinical condition.

Mechanism of Action

Alpha-amylase is an enzyme that catalyzes the breakdown of starch by hydrolyzing internal alpha-1,4 glycosidic bonds.

Its established enzymatic action is carbohydrate digestion. Its proposed anti-inflammatory and anti-edematous effects in medicinal preparations have been investigated, but the mechanism and clinical benefits are not sufficiently established to assume that it reliably reduces swelling in every condition.

Therefore, Megalase should be regarded as a supportive treatment where indicated, rather than a substitute for evidence-based anti-inflammatory treatment or treatment of an underlying infection.

Dosage and Administration

Dosage should follow the Megalase package leaflet or the prescribing healthcare professional's instructions, because age, formulation, and the specific indication affect the recommended regimen.

• Tablets: Swallow the film-coated tablet with water according to the prescribed instructions.
• Syrup: Measure the prescribed dose using an appropriate oral measuring device.
• Do not exceed the recommended dose or duration.
• Do not use the medicine for persistent symptoms without medical advice.

Some alpha-amylase products have different age restrictions and dosing schedules. Do not transfer a dosage schedule from another brand or formulation to Megalase without verifying the product-specific instructions.

Possible Side Effects

Possible adverse effects may include:

• Allergic reactions, including skin rash or itching.
• Gastrointestinal discomfort.
• Nausea or other digestive symptoms.
• Rarely, more serious hypersensitivity reactions.

Stop taking the medicine and seek urgent medical attention if swelling of the face or throat, difficulty breathing, or another severe allergic reaction occurs.

Warnings and Precautions

• Allergy: Do not use if you have a known allergy to alpha-amylase or any component of the formulation.
• Persistent symptoms: Seek medical advice if symptoms worsen or do not improve within five days, or sooner if they are severe.
• Fever or infection: Fever, severe throat pain, difficulty swallowing, or purulent secretions may require medical assessment and specific treatment.
• Children: Use the syrup only according to the approved age-specific instructions.
• Pregnancy and breastfeeding: Consult a healthcare professional before use.
• Excipients: Check the leaflet for sugars, preservatives, and other ingredients, particularly if you have relevant dietary restrictions or sensitivities.

Storage

• Store according to the manufacturer's instructions on the packaging.
• Keep the bottle tightly closed after use.
• Use the syrup within the specified period after opening, if one is stated in the leaflet.
• Keep out of the reach and sight of children.
• Do not use after the expiry date.

References

1. French Public Medicines Database — Ministry of Health (.gouv.fr): Official product information for alpha-amylase 3000 CEIP tablets, including composition and indications. Read tablet product information.
2. French Public Medicines Database — Ministry of Health (.gouv.fr): Official product information for alpha-amylase 200 CEIP/mL syrup. Read syrup product information.
3. PubMed / National Library of Medicine (.gov): Published research examining alpha-amylase as an anti-inflammatory agent. Read the JAMA study.
4. National Center for Biotechnology Information (NCBI) (.gov): Overview of amylase structure and its established role in starch digestion. Read the scientific overview.

Patient Disclaimer

This description is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Megalase should be used according to its approved product leaflet and the advice of a qualified healthcare professional. Its anti-inflammatory benefits may vary, and evidence for alpha-amylase in treating inflammation is limited. Seek medical assessment for persistent or worsening symptoms, fever, severe pain, or difficulty swallowing or breathing. Do not use this information to self-diagnose or replace prescribed treatment.